Doctor profile · Federal record
Dr. SEKOU RAWLINS, MD
Gastroenterology Physician (CMS: GASTROENTEROLOGY) · EAST SYRACUSE, NY
- NPI 1851336366
- Accepts Medicare
- MIPS 98.3 / 100 · 2023
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5000 CAMPUSWOOD DRIVE, SUITE 200
EAST SYRACUSE, NY 13057
(315) 234-6677
fax (315) 234-4808
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- July 12, 2024
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- New York #248138
- Medicaid
- NY #02646197
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1851336366. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
480
Distinct HCPCS
9
Medicare allowed
$67,666
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 144 | 104 | $118 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 74 | 74 | $244 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 69 | 66 | $97 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 68 | 68 | $133 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 51 | 51 | $161 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 32 | 26 | $88 | |
G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk | 16 | 16 | $177 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 13 | 13 | $156 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 13 | 11 | $71 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 50. This provider delivers 9.6× the peer median.Open Payments
Industry payments received
All-time total
$12,531
Transactions
60
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 23 | $11,879.48 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $150.47 | |
| PFIZER INC. | 4 | $112.16 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $109.01 | |
| Janssen Biotech, Inc. | 3 | $60.66 | |
| Ferring Pharmaceuticals Inc. | 2 | $41.08 | |
| GENZYME CORPORATION | 1 | $29.93 | |
| Ardelyx, Inc. | 1 | $24.39 | |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $23.95 | |
| Intercept Pharmaceuticals, Inc. | 1 | $23.50 | |
| Phathom Pharmaceuticals, Inc. | 1 | $19.97 | |
| AIMMUNE THERAPEUTICS, INC. | 1 | $19.44 | |
| Gilead Sciences, Inc. | 1 | $18.54 | |
| Lilly USA, LLC | 1 | $18.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
898
Patients
241
Total drug cost
$789,107
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Famotidine | Generic | 168 | 43 | $3,786 |
| Omeprazole | Generic | 139 | 50 | $2,771 |
| Pantoprazole Sodium | Generic | 125 | 37 | $2,936 |
| Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine) | Brand | 75 | 18 | $2,442 |
| Linzess (Linaclotide) | Brand | 64 | 16 | $52,829 |
| Sodium Chloride (Sodium Chloride 0.45 %) | Brand | 59 | 0 | $2,279 |
| Dicyclomine Hcl | Generic | 54 | 17 | $1,040 |
| Loperamide (Loperamide Hcl) | Brand | 35 | 0 | $1,671 |
| Plenvu (Peg3350/Sod Sul/Nacl/Kcl/Asb/C) | Brand | 29 | 29 | $4,191 |
| Sucralfate | Generic | 29 | 0 | $2,189 |